PTC Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on PTC Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date PTC Therapeutics Inc Strategy Report
- Understand PTC Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on PTC Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4059922A1 | Application | POLYMORPHE UND AMORPHE FORMEN VON (R) (-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTTERSÄUREAMID | A61K31/122; A61K31/164; A61P13/02; A61P13/12; A61P21/00; A61P21/02; A61P21/04; A61P25/00; A61P25/02; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P27/02; A61P27/06; A61P27/16; A61P3/00; A61P3/02; A61P3/10; A61P35/00; A61P39/02; A61P43/00; A61P7/00; A61P7/06; A61P9/00; A61P9/10; C07B2200/13; C07B57/00; C07C215/08; C07C215/28; C07C215/30; C07C231/12; C07C235/78; C07C2601/16 | September 21, 2022 |
DK3889142T3 | Application | 1,2,4-OXADIAZOLBENZOESYREFORBINDELSER OG DERES ANVENDELSE TIL NONSENSE-SUPPRESSION OG BEHANDLING AF SYGDOM | A61K31/4245; A61K31/4439; A61K31/454; A61K31/4545; A61K31/5377; A61K31/655; A61K45/06; A61K9/0053; A61K9/12; A61K9/48; A61P27/02; C07D271/06; C07D271/12; C07D285/14; C07D413/02; C07D413/04; C07D413/10 | September 12, 2022 |
CA2842486C | Grant | METHODS FOR OXIDATION OF ALPHA TOCOTRIENOL IN THE PRESENCE OF NON-ALPHA TOCOTRIENOLS | A61P21/00; A61P27/02; A61P43/00; C07C2601/16; C07C403/08; C07C46/06; C07D311/72 | September 06, 2022 |
AU2019294482B2 | Grant | Heteroaryl compounds for treating Huntington's disease | A61K31/454; A61K31/5025; A61P25/00; A61P25/14; A61P25/28; C07D417/14; C07D471/04; C07D487/04; C07D498/04; C07D513/04; C07D519/00 | September 01, 2022 |
US20220273661A1 | Application | USE OF SEPIAPTERIN AND METABOLITES THEREOF TO TREAT RADIATION EXPOSURE | A61K31/519; A61P39/00 | September 01, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer